Skip to main content
Home

Breadcrumb

  1. Home
  2. News
  3. Search results
Displaying results 526 - 550 of 2484 Clear search
Zyme Communications
ProImmune
Healthcare and Life Science 30 Oct 2025

ProImmune Ltd introduces ProVE® SL Self-Loading MHC Class I Monomers to improve T cell research flexibility

Oxford, UK – 30 October 2025 – ProImmune Ltd, a global leader in life science reagents and services, announces the launch of its new ProVE® SL Self-Loading MHC Class I Monomers.

Babraham Research Campus Ltd
Branded image with quote taken from the article, featuring LiveLabs and Forth logo.
Healthcare and Life Science 29 Oct 2025

Forth Therapeutics: From LiveLabs to their own space at Babraham

Forth Therapeutics: From LiveLabs to their own space at Babraham

Team Consulting Ltd
a In vivo cell
Healthcare and Life Science 29 Oct 2025

A pivot from in vivo to ex vivo cell therapy

October 2025 marked a watershed moment in the evolution of advanced therapies. After years of investment and scientific breakthroughs in ex vivo cell therapy – particularly CAR-T and other autologous approaches – the tide has turned. A growing number of strategic decisions from major pharmaceutical companies signals a pivot: is ex vivo out and in vivo in?

Cambridge University Hospitals NHS Foundation Trust
Berlin Symposium
Healthcare and Life Science 29 Oct 2025

CAMEO team deliver symposium on mid-life psychosis at international conference

CPFT mental health and lived experience experts (pictured) from our CAMEO early intervention service were invited to present a symposium on mid-life psychos

Wellcome Sanger Institute
London underground
Healthcare and Life Science 29 Oct 2025

Origins of the ‘London Underground mosquito’ uncovered, shedding light on West Nile virus transmission

New research has uncovered the ancient origins of an urban mosquito species, Culex pipiens form molestus, also known as the ‘London Underground mosquito’ – disproving a long-held theory of when it first evolved.

Sable&Hawkes
Branding, grapic design and content creation specialists across all communication channels Cambridge.
Communications, Healthcare and Life Science 28 Oct 2025

Sable&Hawkes to support College of Paramedics on brand and design

Cambridge-based brand and design agency Sable&Hawkes has been appointed to support the College of Paramedics with branding, design and content across its communications and channels.

Zyme Communications
www.qureight.com
Healthcare and Life Science, Science and Engineering 27 Oct 2025

Qureight’s Vascul8 model validated to improve care for pulmonary vascular disorders

Study published in ‘American Journal of Respiratory Cell and Molecular Biology’ validates Qureight’s deep-learning models and imaging platform beyond fibrotic lung disease, into new therapeutic areas for severe respiratory diseaseData demonstrate sensitive quantificatio
Team Consulting Ltd
The Tympa Ear and Hearing Health Solution
Healthcare and Life Science 24 Oct 2025

The DBA Design Effectiveness Award shortlist - TympaHealth and Team Consulting on the shortlist

The Tympa Ear and Hearing Health Solution has been shortlisted for the 2026 DBA Design Effectiveness Award! The portable, all-in-one hearing health system developed by TympaHealth in collaboration with Team Consulting, has been recognised for its impact on patients and design excellence.

Plain Sailing Motivation
Sarah Stones is sitting at a table wearing a purple shirt and smiling at a client who is just visible to the right-hand side of the shot.
Communications, Healthcare and Life Science, Other 24 Oct 2025

Transforming your space and mindset with the Marie Kondo method

The Marie Kondo method, also known as the KonMari method, can transform your physical space AND your mindset. I find that decluttering our environments can lead to a more organised and joyful life and this is how you can do it...

cambridge
Healthcare and Life Science, Local Government, Property and Utilities, Science and Engineering 23 Oct 2025

Jobs, homes and better transport links for the Oxford Cambridge Growth Corridor

The government is going further and faster on growth with over £500 million investment for new homes, infrastructure and business space for the Oxford to Cambridge Growth Corridor.

One Nucleus
BioBeat
Healthcare and Life Science 23 Oct 2025

BioBeat: Launching the next chapter

BioBeat is joining the One Nucleus hub for life science innovation 

Cambridge, UK: 23 October 2025

Deborah Prentice, Andy Neely OBE, Kathryn Chapman, Michael Anstey, Jim Glasheen
Healthcare and Life Science, Science and Engineering 23 Oct 2025

Cambridge tops UK for science investment as US capital surges into tech and life sciences

Cambridge is now the UK’s most investible hub for science, according to a new data report which reveals how the Cambridge region has had the highest growth of any UK region outside the capital in the last decade and attracting unprecedented levels of international capital.

Zyme Communications
logo
Healthcare and Life Science 23 Oct 2025

OMED Health Partners with Aviva to support the digestive health of employees

75 Aviva employees to gain pilot access to doctor-led OMED Health Plans, which include the use of the OMED Health Breath Analyzer and mobile appCollaboration will evaluate the impact of the OMED solution on the digestive health and quality of life of participants in a w
The Marketing Centre
Isogenica
Healthcare and Life Science, Science and Engineering 23 Oct 2025

Case study: How Isogenica built its biggest-ever pipeline with 100+% revenue growth

Isogenica, a Cambridge-based biotech pioneering synthetic VHH antibody discovery, went from passive sales and virtually no pipeline to global CRO partnerships, multiple biotech client wins, and the largest commercial pipeline in its history.

Zyme Communications
Biodesix logo
Healthcare and Life Science 22 Oct 2025

Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR High Complexity Assays

Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing

Zyme Communications
ProImmune’s new headquarters at Oasis Park, Oxford
Healthcare and Life Science 22 Oct 2025

ProImmune expands into new 18,000 sq ft global headquarters enabling major expansion in immunology and life science innovation

Move follows ProImmune’s recent acquisition of Oasis Park a 70,000 sq ft Business and Light Industrial Park in Oxford, UKIncreased operational capacity enables accelerated development of ProImmune’s REVEAL® Immunogenicity System and Ankyron® target
Team Consulting Ltd
A phone with digital IFU's on with PDA award win logo 2025
Healthcare and Life Science 21 Oct 2025

Second PDA Innovation Award win for AstraZeneca and Team Consulting

For the second year in a row AstraZeneca and Team Consulting have won the PDA Drug Delivery Partnership Innovation Award, this time for the development of an innovative digital IFU platform designed for on-market autoinjectors. The award, presented at the 2025 PDA Universe of Pre-Filled Syringes conference, recognises technical innovations in the field of drug delivery as well as effective…

Zyme Communications
Bio-Rad logo
Healthcare and Life Science 21 Oct 2025

Bio-Rad’s iQ-Check Enterobacteriaceae Kit validated for detection of Enterobacteriaceae in infant formula and cereals

Certified by MicroVal for Detection of Enterobacteriaceae Including Salmonella, Cronobacter, and E.coli as Indicator of Process Effectiveness to Eliminate Contaminants in Infant Formula and Related Ingredients.

Zyme Communications
Enamine
Healthcare and Life Science 21 Oct 2025

Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral

Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate2,000 new compounds generated for the programme are now available from Enamine’s catalogue
TTP plc
BLE Antenna Design for Implantable Continuous Glucose Monitors
Healthcare and Life Science, Science and Engineering 21 Oct 2025

TTP improves Bluetooth connectivity for implantable continuous glucose monitors

TTP’s Biosensing team has tackled one of the biggest challenges in implantable continuous glucose monitors: achieving reliable Bluetooth® Low Energy (BLE) connectivity within extreme size and power constraints. By taking a system-level approach that integrates RF design, antenna miniaturisation, and real-world testing, the team has demonstrated how dependable wireless performance can be achieved…

electronRx Limited
population health
Healthcare and Life Science 21 Oct 2025

Population health in respiratory care: From data to actionable insights

In an era where healthcare systems face mounting pressures from chronic disease burdens, population health has emerged as a strategic framework to improve outcomes across communities rather than focusing solely on individual patients.

Arthur Rank Hospice Charity
Female outside holding certificates
Charity and Social Care, Communications, Healthcare and Life Science, Other 20 Oct 2025

Arthur Rank Hospice Charity and Cambridgeshire County Council collaborate

Arthur Rank Hospice Charity collaborate with Cambridgeshire County Council

Zyme Communications
https://mosaic-tx.com/
Healthcare and Life Science, Science and Engineering 20 Oct 2025

Mosaic Therapeutics appoints Thomas Fuchs as CEO

Former CEO of Cimeio Therapeutics, and Global Haematology Franchise Head at Roche-Genentech, brings extensive track record of strategic and operational leadershipAppointment strengthens executive leadership team and supports transition into clinical development
Zyme Communications
giles AI
Healthcare and Life Science 20 Oct 2025

giles introduces AI agent to accelerate healthcare and life science research

AI tool connects researchers to verified medical and life sciences global databases, enabling accurate extraction and summarisation of academic papers, journals, and articlesgiles will be showcased at ISPOR Europe 2025, Glasgow, 9-12th November, booth 314
Zyme Communications
Prof. Kevin Chalut, CSO and Co-Founder, and Dr. Léa Wenger, CEO and Co-Founder, Cyclana Bio	The Cyclana Bio team
Healthcare and Life Science 20 Oct 2025

Cyclana Bio raises £5M to advance drug discovery for Endometriosis

Co-led by NfX and Eka VC, investors include Cocoa VC, Wilbe, and Angel investorsInvestment will support development of whole tissue-based platform for identification of druggable targets and scaling of observational clinical trial

Cambridge, UK,

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 20
  • Page 21
  • Current page 22
  • Page 23
  • Page 24
  • …
  • Next page ›
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS